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Emergence of multidrug-resistant Salmonella typhimurium strains, especially the ACSSuT
and nalidixic acid R types, has signiﬁcantly compromised the effectiveness of current
strategies to control Salmonella infections, resulting in increased morbidity and mortality.
Clinical S. typhimurium isolates recovered in Hong Kong during the period of 2005–2011
were increasingly resistant to ciproﬂoxacin (CIP) and antibiotics of the ACSSuT group.
Our data revealed that oqxAB and aac(6 ′)Ib-cr were encoded on plasmids of various
sizes and the presence of these two elements together with a single gyrA mutation in
S. typhimurium were sufﬁcient to mediate resistance to CIP. Acquisition of the oqxAB
and aac(6 ′)Ib-cr encoding plasmids by S. typhimurium caused a fourfold increase in CIP
minimal inhibitory concentration. Furthermore, the presence of oqxAB and aac(6 ′)Ib-cr in
Salmonella dramatically increased themutation prevention concentration of CIP whichmay
due to mutational changes in the drug target genes. In conclusion, possession of oqxAB
and aac(6 ′)Ib-cr encoding plasmid facilitate the selection of CIP resistant S. typhimurium,
thereby causing a remarkable increase of CIP resistance among clinical Salmonella strains
in Hong Kong.
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INTRODUCTION
Non-typhoidal Salmonella are among the principal bacterial
pathogens implicated in food-borne gastroenteritis worldwide
(Gomez et al., 1997). Antimicrobial agents are not usually required
for treatment in salmonellosis but can be lifesaving in cases of
severe or systemic infections, as well as treatment for elderly
and immunocompromised patients (Hohmann, 2001). Multidrug
resistance in Salmonella has been documented since 1980, a repre-
sentative class of resistant organisms being the ACSSuT resistance
type of Salmonella typhimurium DT104, which originated in the
UK and spread rapidly to the US and other parts of the world
(Centers for Disease Control and Prevention, 1997; Glynn et al.,
1998; Markogiannakis et al., 2000). Hence ﬂuoroquinolones and
the extended-spectrum cephalosporins have become the drugs of
choice for treatment of acute gastroenteritis caused by Salmonella
and other enteric pathogens. Resistance toward quinolone and
ﬂuoroquinolone antimicrobials is mainly due to target muta-
tions in quinolone resistance determining region (QRDR) of
DNA gyrases (gyrA and gyrB) and Type IV topoisomerases
(parC and parE), which subsequently prevent drugs from binding
(Hawkey, 2003). Although high level ﬂuoroquinolone-resistant
Salmonella are known to be associated with speciﬁc serotypes of
Salmonella and have been reported in scattered regions around
the world, their prevalence remains low. This is probably due
to the fact that the process of selection of double gyrA and sin-
gle parC mutations is not very efﬁcient. Nevertheless, several
lines of evidence have suggested that emergence of multidrug
resistant non-typhoidal Salmonella strains has signiﬁcant impact
on the effectiveness of current strategies, including reduced efﬁ-
cacy of early empirical treatment to control and manage diseases
associated with food-borne infections. These include reduced efﬁ-
cacy of early empirical treatment as well as limited choice of
treatment.
Plasmid mediated quinolone resistance (PMQR) genes such
as qnrA, qnrB, qnrC, qnrD, qnrS, qepA, and aac(6 ′)Ib-cr have
been increasingly reported in bacterial pathogens. The qnr type
PMQR genes bind to DNA gyrase and topoisomerase to block
the action of ﬂuoroquinolones resulting in reduced suscepti-
bility to ﬂuoroquinolones (Tran et al., 2005). QepA encodes a
MFS-type efﬂux pump which is able to excrete quinolone into
extracelluar space (Yamane et al., 2007). AAC(6′)Ib-cr acetylates
ciproﬂoxacin (CIP) and norﬂoxacin (Robicsek et al., 2006). It
is postulated that these PMQR genes are able to contribute
to the development of quinolone resistance in these organisms
(Cattoir and Nordmann, 2009). Recently, a novel transmissi-
ble resistance-nodulation-division (RND) efﬂux pump OqxAB,
which mediated resistance to olaquindox, chloramphenicol,
nalidixic acid, and elevated minimal inhibitory concentrations
(MICs) of other antimicrobial reagents including ampicillin, gen-
tamicin, and CIP (MIC between 0.06 and 0.25 μg/ml), has been
identiﬁed (Hansen et al., 2007). OqxAB was encoded on an IncXI
plasmid, pOLA52, harbored by a swine Escherichia coli isolate
(Hansen et al., 2004). More recently, OqxAB was reported to be
prevalent in organisms isolated from pork and pig farms in China
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(Zhao et al., 2010; Liu et al., 2011; Wong and Chen, 2012), as well
as from human food (18). On the other hand, the oqxAB gene has
not been found in clinical isolates until recently, when it became
detectable in clinical strains of E. coli, Salmonella, and Klebsiella
pneumoniae (Kim et al., 2009; Park et al., 2012; Ruiz et al., 2012;
Yuan et al., 2012). The functional and clinical signiﬁcance of this
and other PMQR genes such as qnrA, B, D, and S, which have
also become prevalent in clinical Salmonella isolates (Cavaco et al.,
2009; Ferrari et al., 2011; Kim et al., 2013), remains unclear.
We have previously characterized 239 human clinical S.
typhimurium isolates recovered from hospital patients in Hong
Kong during the period of 2005–2011 for their susceptibilities
to ﬂuoroquinolones and other antibiotics and the prevalence of
PMQR genes. Two PMQR genes, oqxAB and aac(6 ′)Ib-cr, were
found to exhibit close relationshipwith ﬂuoroquinolone resistance
in S. typhimurium. Approximately 44% of the oqxAB-positive S.
typhimurium were resistant to CIP and around 89% of oqxAB,
aac(6 ′)Ib-cr-positive isolates were resistant to CIP, while only
11% of the oqxAB-negative isolates were resistant to CIP (Wong
et al., 2013). In the current study, we want to investigate the
direct association of oqxAB/aac(6 ′)Ib-cr with the development
of ﬂuoroquinolone resistance in S. typhimurium. We conﬁrm
that oqxAB and aac(6 ′)Ib-cr can mediate rapid development of
ﬂuoroquinolone resistance in S. typhimurium and could be a
contributive factors accounting for the increasing prevalence of
ﬂuoroquinolone-resistant Salmonella in Hong Kong in recent
years.
MATERIALS AND METHODS
BACTERIAL STRAINS
239 S. typhimurium previously described clinical isolates were
included in this study (Wong et al., 2013).
PCR AND TARGET GENE MUTATION SCREENING IN
S. typhimurium
The QRDRs of gyrA and parC were ampliﬁed by PCR as pre-
viously described (Chen et al., 2007), followed by determination
of their nucleotide sequences and comparison to the wild-type
S. typhimurium LT2 strain to identify target gene mutations in
the test strains. The gyrA and parC sequences of four Salmonella
isolates, S08-52, S10-9, S05-23, and S05-30, were submitted
to GenBank with the accession numbers for gyrA, KM504240,
KM504241, KM504242, and KM504243 and parC, KM513651,
KM513652, KM513653, and KM513654. The association of Inser-
tion sequence IS26 with oqxAB was determined by PCR using
primers IS26-F(5′GCTGTTACGACGGGAGGAG) and oqx-R (5′
GGAGACGAGGTTGGTATGGA).
CONJUGATION EXPERIMENTS
A conjugative experiment was carried out as previously described
(Jacoby et al., 2003) using sodium azide-resistant E. coli J53
strain as recipient. Brieﬂy, overnight culture of donor and
recipient strains were mixed and collected on a ﬁlter, which
was subjected to overnight incubation on a blood agar plate.
The mixture was then spread on double selective blood agar
plates containing olaquindox (128 μg/ml) and sodium azide
(100 μg/ml).
S1-PFGE AND HYBRIDIZATION
S1-PFGE was conducted to determine the size of large plasmids.
Brieﬂy, agarose-embedded DNA was digested with S1 nuclease
(New England BioLab) at 37°C for 1 h. The restriction fragments
were separated by electrophoresis in 0.5 Tris-borate-EDTA buffer
at 14◦C for 18 h using a Chef Mapper electrophoresis system (Bio-
Rad, Hercules, CA, USA) with pulse times of 2.16 to 63.8 s. Phage
LambdaPFGE ladder (NewEnglandBioLab)was used asDNA size
marker. The gels were stained with GelRed, and DNA bands were
visualized with UV transillumination (Bio-Rad). Chromosomal
and plasmid DNA of S. typhimurium strains were transferred and
cross-linked onto nylon membrane and hybridized with a DIG-
labeled oqxAB probe using DIG High Prime DNA Labeling and
Detection Starter Kit I (Roche) following manufacturer’s instruc-
tions to determine the localization of oqxAB and aac(6 ′)-Ib-cr
genes in S. typhimurium genetic materials.
oqxAB CLONING, PLASMID TRANSFORMATION, AND PLASMID
CURING
Cloning of oqxAB into pTrcHisB (Life Technologies) vector was
done by PCRusing primers pTrc-oqxAB-F (5′TTACTACTCGAGA
ATGAGCCTGCAAAAAAC)andpTrcoqxAB-R (5′AGGATCGAAT
TCCTAGGCGGGCAGATCCTC). pTrc-oqxAB was transformed
into S. typhimurium LT2. Plasmids from clinical strains were
extracted by Qiagen Mini-prep kit, electroporated into S.
typhimurium LT2 and a nalidixic acid and CIP susceptible S.
typhimurium clinical strain 11–28, and selected on plates con-
taining 32 μg/ml olaquindox. Plasmid curing was performed on
clinical S. typhimurium strain 10–63 as previously described with
slight modiﬁcation (Sato et al., 2013). The strain was grown in
3 ml LB at 43◦C for 2 weeks and selected on plates containing 0, 8,
16, 32 μg/ml olaquindox.
MUTATION PREVENTION CONCENTRATION (MPC)
Mutation prevention concentration (MPC) of oqxAB, aac(6 ′)Ib-cr
positive, and negative strains was determined as described pre-
viously (Gebru et al., 2011, 2012). Brieﬂy, MPC was determined
by spreading 1 × 109 cells on LB agar plates containing a range
of concentration of CIP: 0, 0.05, 0.1, 0.25, 0.5, 1, 2, 4, 8, 16,
32 μg/ml. Plates containing CIP were incubated for up to 72 h,
whereas CIP-free plates were incubated for 24 h. Viable counts on
each plate were recorded. MPC was deﬁned as the lowest antibi-
otic concentration at which no colonies were observed. For each
strain, MPC was determined on the basis of the results of at least
three independent experiments.
RESULTS
PMQRS AND SINGLE GyrA MUTATION MEDIATE DEVELOPMENT OF
FLUOROQUINOLONE RESISTANCE IN S. typhimurium
To determine if oqxAB alone or the combination of oqxAB
and aac(6 ′)Ib-cr can contribute to ﬂuoroquinolone resistance,
the effect of interplay between oqxAB, aac(6 ′)Ib-cr, and target
mutations in mediating ﬂuoroquinolone resistance phenotypes in
Salmonellawas studied. Among all oqxAB negative S. typhimurium
organisms, the vast majority of those which exhibited CIP MIC
≤0.05 μg/ml had no mutation in the gyrA and parC genes. Sin-
gle amino acid substitution (D87Y or D87N) in GyrA was often
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detected in strains with CIP MIC between 0.1 and 1 μg/ml.
Interestingly, two CIP-resistant isolates (CIP MIC = 1 μg/ml)
showed only single mutation at D87Y. Double substitution in
GyrA (S83F and D87Y or N) and a single substitution in ParC
(S80I) were consistently detected in those with CIPMIC≥2μg/ml
(Table 1). Among all oqxAB positive S. typhimurium strains, no
mutation was detected in gyrA and parC in strains with CIP
MIC ≤0.05 μg/ml; single mutation in GyrA (D87Y or D87N),
but not in ParC, was detected in strains whose CIP MIC was
between 0.25 and 2 μg/ml. Among all isolates which were pos-
itive to both oqxAB and aac(6 ′)Ib-cr, single mutation in GyrA
(D87Y or D87N), but not in ParC, was detected in strains whose
CIP MIC was between 0.25 and 2 μg/ml, whereas most of the
strains from this category exhibited CIP MIC ≥1 μg/ml. Com-
parative analysis of mutational and drug susceptibility data of
oqxAB negative, oqxAB positive, and oqxAB, aac(6 ′)Ib-cr posi-
tive strains showed that similar mutational proﬁles could result in
drastically different CIP MIC, depending on whether the organ-
ism harbored the oqxAB or oqxAB, aac(6 ′)Ib-cr genes. Strikingly,
simultaneous presence of a single gyrA mutation and oqxAB, or
both oqxAB and aac(6 ′)Ib-cr genes, was sufﬁcient to produce CIP
resistance (CIP MIC = 1 μg/ml); however, double mutations
in gyrA plus a single mutation in parC were required to medi-
ate CIP MIC ≥2 μg/ml when oqxAB was absent. Importantly,
around 98% of oqxAB positive S. typhimurium strains harbored
mutations in the gyrA or parC genes, whereas less than 60% of
oqxAB negative S. typhimurium strains had mutations in either or
both of these two genes (Data not shown). Taken together, these
ﬁndings suggest that acquisition of oqxAB or oqxAB, aac(6 ′)Ib-
cr by S. typhimurium could mediate selection of ﬂuoroquinolone
resistance in S. typhimurium.
TRANSFERABILITY AND GENETIC LOCATION OF oqxAB
Thirty randomly selected oqxAB positive S. typhimurium isolates
were subjected to conjugation experiment to determine the trans-
ferability of the oqxAB gene that they harbored. Surprisingly,
none of the S. typhimurium strains tested was able to transfer
this resistance element to E. coli J53 recipient strain through
conjugation. S1-PFGE and Southern hybridization were per-
formed on four S. typhimurium isolates and it showed that
oqxAB and aac(6 ′)Ib-cr were concurrently present on plasmids
of various sizes in these S. typhimurium isolates, hybridization
results of two of which were shown in Figure 1. In all the
tested S. typhimurium isolates, the oqxAB gene was found to be
ﬂanked by the IS26 fragment in a manner similar to that of the
FIGURE 1 | S1-PFGE and southern hybridization of 16SrRNA, oqxA,
and aac(6 ′)Ib-cr on two oqxAB-positive isolates. Arrows indicated
chromosomal DNA or plasmids harboring oqxAB and aac(6 ′)Ib-cr. 06–53
and 10–63 are oqxAB-positive S. typhimurium clinical isolates; M, Lambda
PFGE marker.
Table 1 | Presence of target mutations in different level of ciprofloxacin MIC of oqxAB positive and negative Salmonella typhimurium isolates.
CIP MIC Clinical S. typhimurium
oqxAB− oqxAB+ oqxAB+, aac(6 ′)Ib-cr+
No. of isolates gyrA parC No. of isolates gyrA parC No. of isolates gyrA parC
≤0.05 104 WT/D87N WT/S80R 1 WT WT 0
0.1 24 D87N WT 0 2 WT WT
0.25 14 D87N WT 1 D87Y WT 1 D87Y WT
0.5 18 D87N WT 3 D87Y WT 3 D87Y WT
1 2 D87Y WT 2 D87Y WT 6 D87Y WT
2 2 S83F, D87G S80R 3 D87Y/D87N WT 35 D87Y/D87N WT
4 0 0 10 D87Y WT
8 0 0 0
≥16 8 S83F, D87G S80R 0 0
Total 172 10 57
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pOLA52 plasmid as previously reported (Norman et al., 2008),
suggesting that the oqxAB gene that was becoming prevalent in
S. typhimurium could have been derived from the original trans-
ferable element located in pOLA52. To test this possibility, we
performed PCR screening to determine if pOLA52 speciﬁc DNA
sequences were prevalent among the test plasmids. To our sur-
prise, however, none of the plasmids that carried oqxAB and
aac(6 ′)Ib-cr contained such sequences of pOLA52 (Data not
shown).
CONTRIBUTION OF oqxAB AND aac(6 ′)Ib-cr TO THE ELEVATED
CIPROFLOXACIN MIC IN S. typhimurium
To directly prove the degree of contribution of oqxAB and
aac(6 ′)Ib-cr to the development of ﬂuoroquinolone resistance in
S. typhimurium, oqxAB was cloned into a pTrc expression vec-
tor and transformed into S. typhimurium LT2 strain. Compared
to the original oqxAB negative S. typhimurium LT2 strain, pTrc-
oqxAB- carrying S. typhimurium LT2 exhibited a CIP MIC of
0.25 μg/ml, with a 20-fold increase. However, S. typhimurium
LT2 carrying pTrc-oqxAB showed much weaker growth than
its parental counterpart, which was presumably due to the ﬁt-
ness cost caused by the over-expression of oqxAB in the host
strain. To overcome this problem, the plasmids that carried
oqxAB and aac(6 ′)Ib-cr were extracted from different clinical S.
typhimurium isolates and electroporated into S. typhimurium LT2
with no success. The plasmids were then electroporated into an
oqxAB-negative S. typhimurium strain 11–28. Upon acquisition
of such plasmid, the CIP MIC of this S. typhimurium strain
increased by approximately fourfold (Table 2). To further prove
the contribution of oqxAB and aac(6 ′)Ib-cr to S. typhimurium
ﬂuoroquinolone resistance, the plasmid carrying such genes in a
clinical S. typhimurium strain 10–63 was cured and it showed that
the curing of the plasmid in 10–63 decreased the CIP MIC by
approximately fourfold (Table 2). Taken together, our data had
proven that oqxAB and aac(6 ′)Ib-cr contributed to about four
fold increase of CIP MIC in S. typhimurium. The MICs of other
antibiotics were also determined for S. typhimurium that acquired
oqxAB, aac(6 ′)Ib-cr encoding plasmids. In addition, it is showed
that acquisition of oqxAB and aac(6 ′)Ib-cr encoding plasmids
ensured resistance to ampicillin, chloramphenicol, streptomycin,
nalidixic acid, sulfamethoxazole, tetracycline, trimethoprim, and
olaquindox in addition to the elevated CIP MIC (Table 2). This
is also consistent to our previous ﬁnding that the presence of
oqxAB in S. typhimurium was associated with the ACSSuT R
phenotype. As much as 56% of oqxAB-positive S. typhimurium
clinical isolates were resistant to ACSSuT, whereas only 14% of
oqxAB-negative isolates were resistant to ACSSuT (Wong et al.,
2013).
CONTRIBUTION OF oqxAB AND aac(6 ′)Ib-cr TO ELEVATED MPC OF
FLUOROQUINOLONE IN S. typhimurium
To validate the hypothesis that oqxAB and aac(6 ′)Ib-cr contributed
to mutation development, MPC of CIP were determined for S.
typhimurium with and without oqxAB. As shown in Table 3,
oqxAB, aac(6 ′)Ib-cr positive clinical Salmonella isolates, 06–57,
07–43, and 08–11 exhibited much higher MPC of CIP than the
oqxAB, aac(6 ′)Ib-cr-negative Salmonella strains, 05–41, 07–54,
and 10–25 (Table 3). Furthermore, although Salmonella 11–28
strain exhibited MPC for CIP of about 0.1 μg/ml, transforma-
tion of plasmids from other clinical Salmonella isolates carrying
oqxAB, aac(6 ′)Ib-cr to Salmonella 11–28 dramatically increased its
MPC to 2∼4 μg/ml. On the other hand, Salmonella 10–63 exhib-
ited MPC of 8 μg/ml, yet the curing of the oqxAB, aac(6 ′)Ib-cr
encoding plasmid led to a slightly decreased MPC (4 μg/ml). The
minimal effect of curing of oqxAB, aac(6 ′)Ib-cr encoding plasmid
on the MPC of 10–63 may be due to the fact that the long-term
starvation stress used to cure the plasmid may have caused stress
response to develop in the isolate, thereby indirectly contributing
to the elevated MPC for strain.
Ten to 63 C. It has been shown that long-term starvation stress
stimulates the stringent SOS response in bacteria, which is essen-
tial in bacteria for acquisition of mutations leading to resistance
to some antibiotic drugs (Fung et al., 2010). Most importantly,
compared to Salmonella 11–28 alone, which did not develop
Table 2 | MIC profiles for Salmonella strains with various oqxAB and aac(6 ′)Ib-cr -borne plasmids.
Strain MIC (μg/ml)
AMP CRO CIP NA TET CHL SUL TRI AMK GEN OLA STE
11–28* ≤4 ≤1 0.012 4 2 ≤4 ≤128 ≤4 ≤4 ≤1 8 8
P06–57# ≥128 ≤1 0.05 16 64 ≥128 ≥1024 32 ≤4 32 128 ≥128
P07–43# ≥128 ≤1 0.05 32 64 ≥128 ≥1024 32 ≤4 32 64 ≥128
P08–11# ≥128 ≤1 0.05 16 64 ≥128 ≥1024 32 ≤4 32 64 ≥128
P10–9# ≥128 ≤1 0.05 16 64 ≥128 ≥1024 32 ≤4 32 128 ≥128
10–63* ≥128 ≤1 1 ≥128 64 ≥128 ≥1024 32 ≤4 ≤1 512 32
10–63C 16 ≤1 0.25 ≥128 2 ≥128 ≥1024 ≤4 ≤4 ≤1 16 8
AMP, ampicillin; CRO, ceftriaxone; CIP, ciproﬂoxacin; NA, Nalidixic acid; TET, tetracycline; CHL, chloramphenicol; SUL, sulfamethoxazole; TRI, trimethoprim; AMK,
amikacin; GEN, gentamicin; STE, streptomycin; OLA, olaquindox.
*Salmonella clinical isolates with various oqxAB, aac(6 ′)Ib-cr background; #transformants with the transformation of oqxAB, aac(6 ′)Ib-cr encoding plasmid from
different clinical Salmonella isolates to parental Salmonella strain 11–28; C, oqxAB, aac(6 ′)Ib-cr encoding plasmid cured strain.
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Table 3 | MICs of nalidixic acid (NA) and ciprofloxacin (CIP) and mutation prevention concentration (MPC) toward CIP of Salmonella isolates
with various background of oqxAB and aac(6 ′)Ib-cr.
Salmonella
Isolate
oqxAB,
aac(6 ′)Ib-cr
QRDR Mutations MIC (μg/ml) MPC
(μg/ml)
GyrA
mutation†
MPC/MIC
GyrA ParC NA CIP CIP
06–57* + WT WT 32 0.1 2 NT 20
07–43* + WT WT 16 0.05 0.5 NT 10
08–11* + WT WT 32 0.1 1 NT 10
05–41* – D87N WT 32 0.025 0.1 NT 4
07–54* – WT WT 16 0.012 0.1 NT 8
10–25* – WT WT 4 0.025 0.1 NT 4
11–28* – WT WT 4 0.012 0.1 WT 8
p06–57# + WT WT 16 0.05 4 D87N 80
p07–43# + WT WT 32 0.05 2 WT 40
p08–11# + WT WT 16 0.05 2 D87G 40
p10–9# + WT WT 16 0.05 2 WT 40
10–63* + D87N WT ≥128 1 8 D87Y 8
10–63c – D87N WT ≥128 0.25 4 D87Y 16
NA, Nalidixic acid; CIP, ciproﬂoxacin.
*Salmonella clinical isolates with various oqxAB, aac(6 ′)Ib-cr background; #transformants with the transformation of oqxAB, aac(6 ′)Ib-cr encoding plasmids from
different clinical Salmonella isolates to parental Salmonella strain 11–28; †GyrA mutation from strains that were selected after MPC assay and have CIP MIC between
0.5 and 4 μg/ml; c, oqxAB, aac(6 ′)Ib-cr encoding plasmid cured strain; NT, Not tested.
gyrA mutation in MPC assay, Salmonella 11–28 transformed with
oqxAB,aac(6 ′)Ib-cr encodingplasmids from Salmonella 06–57 and
08–11 developed single mutation in gyrA, which may partly con-
tributed to the increase of CIP MPC (Table 3). It is probably
due to that the presence of oqxAB and aac(6 ′)Ib-cr may enable S.
typhimurium to survive under ﬂuoroquinolone stress and facilitate
subsequent development of target mutations. Nevertheless, these
data conﬁrm that oqxAB, aac(6 ′)Ib-cr plays a key role in elevated
CIP MIC and MPC, and hence resistance to ﬂuoroquinolone in S.
typhimurium.
DISCUSSION
An important ﬁnding in this work is that the oqxAB and aac(6 ′)Ib-
cr gene products not only directly contribute to the elevated CIP
MIC, but also enhance the ability of S. typhimurium to sur-
vive in an environment with high dose of CIP, which may in
turn facilitate the development of ﬂuoroquinolone resistance. The
mechanism of ﬂuoroquinolone resistance in Salmonella has con-
ventionally been attributed to double mutations in gyrA with or
without a single parC mutation (Casin et al., 2003; Chu et al.,
2005). Unlike E. coli and Campylobacter, double gyrA mutations
in Salmonella were rare and presumably difﬁcult to acquire, there-
fore ﬂuoroquinolone remained an effective treatment of choice
for severe Salmonella infections. In this study, we demonstrated
that acquisition of the oqxAB or oqxAB, aac(6 ′)Ib-cr genes in S.
typhimurium, could mediate development of resistance to CIP
(CIP MIC ≥1 μg/ml). We postulate that the pump activities
and enzymatic hydrolysis of ﬂuoroquinolones enable the organ-
isms to withstand antibiotic pressure for a prolonged period,
during which mutational changes can occur. Elevation of the
antibiotic resistance potential of Salmonella is one way by which
oqxAB can help the host strain to successfully launch clini-
cal infection in human, leading to a dramatic increase in the
proportion of oqxAB positive strains observable among clinical
Salmonella isolates recovered in recent years (Wong et al., 2014).
The increased prevalence of oqxAB positive S. typhimurium in
clinical isolates also contributes directly to a higher percentage of
ﬂuoroquinolone resistance in clinical salmonella strains. In 2011,
the proportion of the oqxAB positive S. typhimurium in Hong
Kong that were found to be resistant to CIP reached 34% (Data
not shown).
The fact that oqxAB could not be found in S. typhimurium
until 2006 may be due to its poor ability to replicate in Salmonella
initially; this notion is supported by the fact that transforma-
tion of oqxAB-borne plasmid to S. typhimurium did not elevate
MIC of CIP in these strains and that direct expression of oqxAB
into S. typhimurium had a ﬁtness cost in this work (Hansen et al.,
2007; Wong et al., 2013). Nevertheless, our data indicate that the
oqxAB gene has adapted to co-exist in S. typhimurium. In this
study, oqxAB were found to be associated with IS26 but not car-
ried by pOLA52-like plasmids, suggesting oqxAB was excised from
pOLA52 and integrated into other plasmids mediated by IS26
transposase. Since no oqxAB encoding plasmid in Salmonella has
been sequenced, the mechanism underlying the co-existence of
oqxAB and aac(6 ′)Ib-cr in over 80% of the oqxAB-positive strain
is not clear. The quick expansion of oqxAB and aac(6 ′)Ib-cr posi-
tive, CIP-resistant S. typhimurium will pose huge threat to efforts
of infection control of Salmonella infections. Urgent actions are
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required to halt further transmission of the oqxAB positive strains
in both environmental and clinical settings. In addition, it remains
to be seen if oqxAB has been taken up by other bacterial species
and whether it plays a role in the evolution of resistance and vir-
ulence traits of various bacterial pathogens. Findings in this work
also highlight a need to investigate the impact of oqxAB in a wide
range of foodborne and zoonotic pathogens.
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